Interest in famotidine as a treatment for COVID-19 (caused by the coronavirus SARS-CoV-2) was triggered by a preliminary report that people in China with COVID-19 who had taken famotidine for its approved use (as an "H2 blocker" to reduce stomach acidity) had better outcomes than people who were not taking it or who had been using other types of acid reducers, such as Prilosec (omeprazole — a proton pump inhibitor or PPI). 

The evidence regarding famotidine and COVID-19:

An article in Science (April 26, 2020) that discusses the findings from China stated: "In reviewing 6212 COVID-19 patient records, the doctors noticed that many survivors had been suffering from chronic heartburn and were on famotidine rather than more-expensive omeprazole (Prilosec), which is a proton pump inhibitor and the medicine of choice both in the United States and among wealthier Chinese. Hospitalized COVID-19 patients on famotidine appeared to be dying at a rate of about 14% compared with 27% for those not on the drug, although the analysis was crude and the result was not statistically significant." The article also notes anecdotal reports in the U.S. of a women who recovered from symptoms of COVID-19 the day after taking a "megadose" of oral famotidine and of "dramatic improvements" in five other sick people (three confirmed for COVID-19) after taking oral famotidine.

A review of the records of 1,620 COVID-19 patients (none of whom required immediate mechanical ventilation) admitted to Columbia University hospital in New York showed that those who had received famotidine (intravenous or oral, to suppress gastric acid) within 24 hours of admission were 70% less likely to have died within 30 days of admission than those who had not received famotidine. There was no association between famotidine and the need for intubation (being put on a ventilator). Among the patients who had received famotidine, 72% had received it orally (10 to 40 mg daily) and 28% intravenously (dose not reported). Interestingly, use of proton pump inhibitors, which more potently suppress gastric acid, was not associated with reduced risk for death or intubation (Freedberg, medRxiv 2020 -- preprint).

A separate study found once-daily use of proton pump inhibitors -- but not H2 blockers like famotidine -- to be associated with a 115% increase in the risk of contracting COVID-19 in comparison to not taking PPIs. Furthermore, there was a 267% increase in risk when PPIs were taken twice daily. The results were based on a national phone survey of 53,130 Americans in May and June 2020. The researchers noted that PPI use is associated with increased risk for other enteric infections, likely because PPIs dramatically reduce stomach acidity that can deactivate bacteria and viruses. For example, a related coronavirus (SAR-CoV-1) is deactivated at a pH of less than 3.0, but twice daily PPI use can increase the 24-hour median pH of the stomach to greater than 6. As twice daily use of PPIs has not been shown to be more effective than once-daily use, the researchers cautioned that PPIs should only be used when necessary and at the lowest effective dose (Almario, Am J Gastroent 2020).

A case study that followed ten adults (ages ranging from 20s to 70s) with COVID-19 who gave themselves high-dose famotidine (ranging from 20 mg to 80 mg three times daily, with most taking the highest dose) for about 5 to 21 days (median of 11 days) found that all reported marked improvements in COVID-19-related symptoms within 24 to 48 hours of starting the drug and none required hospitalization. Cough and shortness of breath improved more rapidly than fatigue. The time period between onset of symptoms and starting famotidine ranged from 2 days to 26 days. Famotidine was well tolerated: 7 patients did not experience any adverse events, two reported dizziness, and one reported gastrointestinal side effects. These are known side effects of famotidine, as discussed below. One patient experienced temporary forgetfulness. All side effects resolved on discontinuation of famotidine (Janowitz, Gut 2020).

Based on computational modeling, it was proposed that famotidine might inhibit an enzyme (3-chymotrypsin-like protease or 3CLpro) essential for processing proteins needed for replication of the SARS-CoV-2 virus (Wu, Acta Pharm Sin B 2020). However, subsequent laboratory research showed that famotidine does not inhibit this enzyme or viral replication (Loffredo, bioRxiv — preprint).

A possible mechanism by which famotidine may work is by inhibiting an enzyme (3-chymotrypsin-like protease or 3CLpro) essential for processing proteins needed for viral replication, according to computational modeling (Wu, Acta Pharm Sin B 2020).

A clinical trial in New York began in April of 2020 in which famotidine is being given intravenously in very large doses to patients hospitalized with COVID-19. Patients receive three intravenous doses daily, each providing 120 mg of famotidine, i.e., 360 mg total per day. (Note: A normal oral daily dose of famotidine for heartburn is 10 to 20 mg up to twice daily.) The study is to be completed in September. 

Until results of this or other trials with famotidine are published, there is no solid evidence that famotidine is effective in treating COVID-19, and there is not even anecdotal evidence that it prevents SARS-CoV-2 infection.

Be aware of risks with famotidine:

Side effects that have been reported with famotidine at a dose of 40 mg at bedtime (taken to treat acute gastrointestinal ulcers) are headache (4.7%), dizziness (1.3%), constipation (1.2%), and diarrhea (1.7%)(Pepcid insert, Drugs@FDA). The study in New York excluded COVID-19 patients with decreased kidney function because high doses of famotidine can cause heart problems in them. Other adverse effects that have been infrequently reported with famotidine use include including jaundice and anorexia; rare cases of blood abnormalities; musculoskeletal pain; seizures; psychiatric disturbances; respiratory reactions (bronchospasm and interstitial pneumonia); various skin effects maladies including, very rarely, epidermal necrosis; tinnitus; and taste disorder. In addition, famotidine should not be used by anyone with an allergy to famotidine or other acid reducers.

Long-term use of famotidine and other medications that lower stomach acidity has been associated with deficiency in vitamin B12 and zinc, possibly due to poorer extraction of these nutrients from foods. Supplementation with these may be advisable with long-term use of famotidine. When discontinuing famotidine, a rebound in gastric acid production can potentially occur, causing abdominal discomfort. To help avoid this, do not stop abruptly, but taper the dose down over several days. 

Also be aware that some over-the-counter formulations of famotidine include substantial amounts of other active ingredients. Pepcid Complete, for example, provides a modest amount of famotidine (10 mg) along with 320 mg of calcium and 70 mg of magnesium per tablet, and no more than two should be taken per day. Excessive intakes of calcium or magnesium from supplements are not advisable.

Join today to unlock all member benefits including full access to all CL Answers and over 1,300 reviews.

Join Now

Join now at


Join the conversation

August 26, 2020

I think it's pretty amazing that any of these drugs are still on the market. Instead of focusing on, say, the health of the lower esophageal sphincter, they'll give drugs that suppress HCl - leading to protein deficiency, compromised acid/immune function and potential malabsorption of minerals ... but hey: they'll continue to sell lots of harmful drugs! I know it's not in CL's mission statement to debunk some of these major, profit-making vehicles, but it would be nice to see alternative viewpoints and data (e.g. the purveyors of the blockers (targeted at GERD, etc.) indicate that there's "too much acid," yet they also claim that the situation gets worse as one ages; but studies are clear that as people age, HCl levels in the stomach go down (one might even draw some interesting mortality conclusions based on it) ... so how does that combination, in the claims, convince anyone at all?). This and other areas of prescription dogma need to be re-examined for the sake of everyone taking them.

October 27, 2020

I just take a Centrum Silver in the morning with famotidine. I'm as far from having a protein deficiency, or any other nutrient deficiency, as you possibly can be! And you say I may not need it. I can FEEL the heartburn, and my doctor concurs that famotidine diminishes that problem! I have no side effects, deficiencies, or abnormal lab tests of any kind on it!

August 22, 2020

The latest I have read about famotidine is that research shows it does not prevent viral replication and thus is unlikely to prevent infection. Whether it helps with the inflammation is unknown.
August 26, 2020

Thank you. We had not seen that article and have now updated the article above.

Elaine L20136
June 7, 2020

Being an RN, I'm concerned that this article, which you cite and which is circulating on the internet, is going to cause people to do a few things: 1. hoard the medication necessary for patients who need it for stomach issues; and, 2. people self-medicating with large doses not prescribed or large-dose-approved by an MD, PA, or NP. Since this "study" only used a cohort of 10 patients, it does not indicate any evidence based best practice for treating, curing, or preventing COVID. I think your last paragraph, discussing famotidine as a potential treatment for COVID, is most important for individuals to read and understand: "Until results of this or other trials with famotidine are published, there is no solid evidence that famotidine is effective in treating COVID-19, and there is not even anecdotal evidence that it prevents SARS-CoV-2 infection."
June 8, 2020

We appreciate and share your concern and hope our coverage of this topic accurately presents the current level of information and informs regarding potential risks. We continue to update this article as information becomes available.

May 3, 2020

Because of steroid therapy my doctor wanted me to take an acid blocker. PPIs give me gas so I have been taking Pepcid 20 2x a day then cut down to 20 mgm. I recently started to notice palpitations more and more frequently. I looked up this drug on Epocrates ( I’m a retired medical professional) which indicated abnormal heart rhythm as an adverse reaction. I stopped the Pepcid and my heart is now totally regular- no more palpitations. I add that extensive testing in the past showed no cardiac abnormalities.

May 17, 2020

What do you make of this study? Or this:

Licorice has its own side effects of course. Would DGL work at all?

Thanks for all your great work!

AILEE 20862
September 3, 2020

From personal experience, 6-9 months of cycles of H2blockers,PPIs, antacids (incl.the perfunctory elimination of GERD exacerbants like no coffee,mint,spices,smoking, elevate head when sleeping etc.etc.) did nothing to eliminate the GERD symptons. Yet within a few days of ACV and digestive enzymes literally eased the situation and are a routine adjunct to being GERD-FREE.

September 28, 2020

Rebecca, I can't imagine that DGL would work for this since DGL, by its very name (Deglycyrrhizinated), has the glycyrrhizin REMOVED from it. According to the articles that you linked, the study was showing whether glycyrrhizin, itself, would help.

April 29, 2020

Thank you for your analysis, particularly in pointing out the risks of acid blockers. Use of an acid blocker does not seem logical on its face, since we know that stomach acid is one of our bodies' most important defense mechanisms against pathogens, including SARS-CoV-2 which is known to attach to the GI tract and cause nausea & loss of appetite in at least 30% of Covid patients.
April 29, 2020

Computer modeling has suggested that the famotidine molecule may inhibit an enzyme needed for viral replication. This is discussed in the Science article referenced above.

April 29, 2020

Any thoughts on cimetidine, commonly known as Tagamet, that has potent immune enhancing properties? Thank you!
April 30, 2020

We're not aware of any evidence for cimetidine and COVID-19 at this time.

June 3, 2020

It’s important to distinguish between two categories of “acid blockers.” Proton Pump Inhibitors (PPIs) that end in -azole, destroy the acid factory in the gut. The risks generally outweigh the benefits for long term use.

H2 antagonists are antihistamines that block some or most acid production. People build up a tolerance to them and they eventually will be less effective over time. They are generally safe for short or long term use, per peer-reviewed studies.

July 16, 2020

I stopped taking PPI in Jan of this year after noticing a number of side effects. PPI just treated the symptoms which always returned. After doing some research, I found out having no gall bladder, I need stomach acid. They we’re doing more harm than helping. Best decision for me.

August 26, 2020

Glad you've come to that conclusion; in fact, everyone needs a healthy level of HCl (except in the cases where there's a true stomach sensitivity (or ulcer), that underlying condition needs to be handled ASAP so that the person can return to normal, healthy digestive function). I'm sorry about your GB, but glad that it pushed you to the realization.

Join today to unlock all member benefits including full access to CL Answers

Join Now

Join now at